Latest Pulmonary embolism Stories
The DrugNews Center is the web’s most comprehensive source for prescription drug warnings, research and legal news.
The International Society on Thrombosis and Haemostasis partners with thrombosis related organizations from every continent to launch World Thrombosis Day focused on single cause of top 3 cardiovascular
- Subgroup analyses of East Asian populations from two phase 3 studies, ENGAGE AF-TIMI 48 and Hokusai-VTE, showed consistent results compared to the global study populations from these trials(1,2,3,4) TOKYO,
The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news.
Insufficient medical care of blood clots in the extremities is prevalent, but Dr.
Merck & Co.
SAN ANTONIO, March 18, 2014 /PRNewswire/ -- BiO2 Medical, Inc. is proud to announce the Angel® Catheter Early Feasibility Clinical Study has enrolled its first 3 subjects.
http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news.
The DrugRisk Center is the largest source on the Web for information on prescription drug side effects and legal news.
-- Bayer's Adempas (riociguat tablets) approved for the treatment of pulmonary arterial hypertension (PAH)(1), which affects up to 2000 Canadians(2) -- Adempas provides
- The governor of a province or people.